Remifentanil Uses, Dosage, Side Effects and Interactions
Ultiva
Ultiva was the first remifentanil product the FDA approved, in July 1996. An FDA-approved generic with the same active ingredient is listed.
Remifentanil is a very short-acting opioid pain medicine given through a vein (IV) by anesthesia professionals during general anesthesia, monitored anesthesia care, and in the immediate period after surgery.
Quick links
Ask Anything About RemifentanilType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Remifentanil in Short
- Drug class Opioid Agonist How the FDA classifies it
What it treatsRemifentanil is an opioid pain reliever given only by IV. It is used during surgery and procedures. Both Remifentanil Hydrochloride for injection and Ultiva carry the same uses. Pain control during the start and maintenance of general anesthesia, for inpatient and outpatient procedures Continued pain control right…
- How you get it Prescription only Controlled substance, Schedule II
- Comes asInjection (into a vein)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Remifentanil (Ultiva) is an opioid pain medicine given through a vein by anesthesia teams during and just after surgery and procedures. On the market since about 1996, with FDA-approved generics listed, it is a familiar choice when the team wants pain relief that starts fast and fades within minutes, since blood enzymes break it down. Most people notice little beyond some nausea or vomiting afterward, and the team watches for and treats slow heart rate, low blood pressure and muscle stiffness. Its boxed warning is for life-threatening slowed or stopped breathing, plus addiction, abuse and misuse, which is why it is used only where trained staff watch your breathing.
Key Takeaways From the HelloPharmacist Team
- Expect it as a drip through your IV, run by a pump and adjusted by your anesthesia team; you never give it yourself.
- Expect its pain relief to wear off within minutes once the drip stops, so your team plans longer-lasting pain control before it ends.
- Tell your anesthesia team about every medicine you take, especially sedatives, sleep aids, opioids and antidepressants, which can interact dangerously.
- Skip alcohol for 24 hours after surgery, because it adds to the sleepiness and slowed breathing that opioids can cause.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Remifentanil.
Remifentanil can cause serious, life-threatening, or fatal breathing problems, especially when it is started or the amount is increased. Careful dosing is essential.
As an opioid, it also carries risks of addiction, abuse, and misuse, which can lead to overdose and death. Your risk is assessed and rechecked regularly.
Taking it with benzodiazepines or other CNS depressants, including alcohol, may cause profound sedation, breathing trouble, coma, and death. These combinations are reserved for people with no adequate alternatives.
Patient Information Guide for Remifentanil
What It’s Used For
Remifentanil is an IV opioid pain medicine used around surgery. Remifentanil Hydrochloride for injection and Ultiva share these uses:
- Pain control during the start and maintenance of general anesthesia (inpatient and outpatient procedures)
- Continued pain control in the immediate period after surgery in adults, under direct supervision of an anesthesia practitioner in a recovery or intensive care setting
- Pain control as part of monitored anesthesia care in adults
How It Works
Remifentanil is a μ-opioid agonist. It attaches to opioid receptors to reduce pain. It acts quickly and wears off quickly.
Unlike most opioids, it is broken down by esterases in blood and tissues, not by the liver. Opioid blockers such as naloxone can reverse its effects.
Drug Class
Drug Class
- Opioid Agonist
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Opioid Agonist
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Full Opioid Agonists
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Remifentanil in the FDA’s index.
From our Patient Information GuideRemifentanil is a μ-opioid agonist. It attaches to opioid receptors to reduce pain. It acts quickly and wears off quickly. Unlike most opioids, it is broken down by esterases in blood and tissues, not by the liver. Read How Remifentanil Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Remifentanil in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Opioid anesthetics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Remifentanil is given only into a vein by trained anesthesia staff, either as a continuous infusion through a pump or as occasional extra doses during anesthesia. It must be diluted first.
Your team adjusts the amount based on how you respond, and starting doses are lower for adults over 65.
- It is not taken at home, so there are no missed doses to manage
- Pain control is planned before the infusion ends because effects fade quickly
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Pain control during general anesthesia
Adults · Induction Starting dose 1 mcg/kg
- Continuous IV infusion 0.5 – 1 mcg/kg/min
- An initial dose of 1 mcg/kg may be administered over 30 to 60 seconds
IV means given into a vein (intravenous).
Adults · Maintenance with nitrous oxide (66%) Dose 1 mcg/kg
- Continuous IV infusion 0.4 mcg/kg/min (range 0.1 – 2 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
IV means given into a vein (intravenous).
Adults · Maintenance with isoflurane (0.4 to 1.5 MAC) Dose 1 mcg/kg
- Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 2 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
IV means given into a vein (intravenous).
Adults · Maintenance with propofol (100 to 200 mcg/kg/min) Dose 1 mcg/kg
- Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 2 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
IV means given into a vein (intravenous).
Babies from birth to 2 months old · Maintenance with nitrous oxide (70%) Dose 1 mcg/kg
- Continuous IV infusion 0.4 mcg/kg/min (range 0.4 – 1.0 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
Good to know
Clearance in neonates is highly variable, on average two times higher than in young healthy adults; increased infusion rate or additional boluses may be needed
IV means given into a vein (intravenous).
Children 1 to 12 years old · Maintenance with halothane (0.3 to 1.5 MAC) Dose 1 mcg/kg
- Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 1.3 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
IV means given into a vein (intravenous).
Children 1 to 12 years old · Maintenance with sevoflurane (0.3 to 1.5 MAC) Dose 1 mcg/kg
- Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 1.3 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
IV means given into a vein (intravenous).
Children 1 to 12 years old · Maintenance with isoflurane (0.4 to 1.5 MAC) Dose 1 mcg/kg
- Continuous IV infusion 0.25 mcg/kg/min (range 0.05 – 1.3 mcg/kg/min)
- Supplemental IV bolus 1 mcg/kg
IV means given into a vein (intravenous).
Pain control after surgery in a recovery or intensive care setting
For adults
Continuous IV infusion 0.1 mcg/kg/min (range 0.025 – 0.2 mcg/kg/min); supplemental bolus not recommended
IV means given into a vein (intravenous).
Pain control during monitored anesthesia care
Adults · Single dose, Ultiva alone Usual dose 1 mcg/kg once
- 1 mcg/kg over 30 to 60 seconds, given 90 seconds before local anesthetic
Adults also given 2 mg midazolam · Single dose with midazolam Usual dose 0.5 mcg/kg once
- 0.5 mcg/kg over 30 to 60 seconds, given 90 seconds before local anesthetic
Pain control during coronary artery bypass surgery
For adults · Maintenance
Dose 0.5 to 1 mcg/kg
- Continuous IV infusion 1 mcg/kg/min (range 0.125 to 4 mcg/kg/min)
- Supplemental IV bolus 0.5 to 1 mcg/kg
IV means given into a vein (intravenous).
Side Effects
The most common side effects are related to how opioids affect the body.
Common side effects
- Slowed or shallow breathing (respiratory depression)
- Slow heart rate (bradycardia)
- Low blood pressure (hypotension)
- Muscle stiffness or rigidity
- Nausea and vomiting
When to get medical help
- Trouble breathing, very slow breathing, or extreme sleepiness: tell your care team right away
- Chest or muscle stiffness that makes breathing difficult
- Signs of serotonin syndrome, such as agitation, hallucinations, fast heartbeat, fever, stiff or twitching muscles, or diarrhea
- Pain that gets worse or feels more sensitive after opioid dose increases (opioid-induced hyperalgesia)
- Severe allergic reaction (anaphylaxis)
- Dizziness or fainting from low blood pressure
- Worsening seizures if you have a seizure disorder
Warnings and Precautions
- Breathing depression: can be fatal. Risk is highest at the start or after a dose increase, and in people with COPD, older adults, or frail patients.
- Addiction, abuse, and misuse: it is a Schedule II controlled substance.
- Sedatives and alcohol: combined use can cause profound sedation, coma, and death.
- Muscle and chest wall rigidity: related to dose and speed of administration.
- Slow heart rate and low blood pressure: monitored during dosing.
- Awareness during surgery: reported in patients under 55 when used with low propofol infusion rates.
- Opioid-induced hyperalgesia: pain that paradoxically worsens.
- Serotonin syndrome: a potentially life-threatening reaction with serotonergic drugs.
Interactions
Several medicines can add to remifentanil's effects or cause dangerous reactions.
- Benzodiazepines, sedatives, muscle relaxants, antipsychotics, other opioids: more sedation and breathing depression
- Alcohol: avoid for 24 hours after surgery
- Serotonergic drugs (SSRIs, SNRIs, tricyclics, triptans, tramadol, linezolid, methylene blue): risk of serotonin syndrome
- MAO inhibitors: not recommended within 14 days of use
- Buprenorphine, butorphanol, nalbuphine, pentazocine: may reduce pain relief or trigger withdrawal
- Blood products in the same IV line: may inactivate remifentanil
Interactions Listed in the FDA-Approved Label
From the Remifentanil prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Benzodiazepines and other CNS depressants For example: alcoholWhat happensAdditive effects increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.What to doLimit dosages and durations to the minimum required; follow patients closely for respiratory depression and sedation; advise avoiding alcohol for 24 hours after surgery.
-
Serotonergic drugsWhat happensConcomitant use of opioids with drugs affecting the serotonin system has resulted in serotonin syndrome.What to doIf concomitant use is warranted, observe the patient carefully, especially at treatment start and dose adjustment; discontinue remifentanil if serotonin syndrome is suspected.
-
Monoamine oxidase inhibitors (MAOIs)What happensInteractions with opioids may appear as serotonin syndrome or opioid toxicity (e.g., respiratory depression, coma).What to doNot recommended in patients taking MAOIs or within 14 days of stopping them; if urgent use is necessary, use test doses and frequent titration of small doses while closely monitoring blood pressure and CNS and respiratory depression.
-
Mixed agonist/antagonist and partial agonist opioid analgesics (butorphanol, nalbuphine, pentazocine, buprenorphine)What happensMay reduce the analgesic effect of remifentanil and/or precipitate withdrawal symptoms.What to doIf concomitant use is warranted, observe the patient carefully, especially at treatment start and dose adjustment; consider discontinuing remifentanil if the patient is not responding appropriately and institute alternative analgesic treatment.
-
SuccinylcholineWhat happensIn animals the duration of muscle paralysis from succinylcholine is not prolonged by remifentanil.
Read the label’s full interactions text
7 DRUG INTERACTIONS Table 18 includes clinically significant drug interactions with remifentanil Hydrochloride for injection. Table 18: Clinically Significant Drug Interactions with Remifentanil Hydrochloride for Injection Benzodiazepines and other Central Nervous System (CNS) Depressants Clinical Impact: Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants including alcohol, increases the risk of hypotension, respiratory depression, profound sedation, coma, and death. Intervention: Limit dosages and durations to the minimum required. Follow patients closely for signs of respiratory depression and sedation. Patients should be advised to avoid alcohol for 24 hours after surgery. Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol. Serotonergic Drugs Clinical Impact: The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome. Intervention: If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Discontinue Remifentanil Hydrochloride for injection if serotonin syndrome is suspected. Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Not for epidural or intrathecal use
- Not for people with a hypersensitivity (such as anaphylaxis) to remifentanil
- Use extra caution with COPD, reduced breathing reserve, head injury, brain tumor, seizure disorders, biliary tract disease, or low blood volume
- Pregnancy: may cause fetal harm; not recommended during or just before labor when other options are more appropriate
- Breastfeeding: watch the infant for sedation and breathing problems
- Children: not studied for postoperative pain or monitored anesthesia care
- Older adults: more sensitive, with starting doses cut by 50%; kidney function may matter
- Severe obesity calls for extra caution
Overdose
Overdose can cause very slow breathing, deep sleepiness progressing to coma, cold clammy skin, small pupils, slow heart rate, and low blood pressure. Treatment focuses on protecting the airway and supporting breathing. The infusion is stopped, and reversal medicines such as naloxone or nalmefene may be given if breathing or circulation is seriously affected.
Half-Life and How Your Body Processes It
Remifentanil's effective half-life is only about 3 to 10 minutes, and its duration does not lengthen with prolonged infusion. It is broken down mainly by esterases in blood and tissues, not the liver. Its nearly inactive breakdown product is cleared by the kidneys. Liver or kidney impairment does not change how remifentanil itself is processed.
Storage
Stored at 2° to 25°C (36° to 77°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Remifentanil: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Remifentanil — the kind of thing our pharmacy team would talk through with you at the counter.
What is remifentanil used for?
How long does remifentanil last?
Can I drink alcohol after surgery with remifentanil?
What side effects should I expect?
Do I need to worry about other medicines I take?
Is remifentanil safe in pregnancy or while breastfeeding?
Is remifentanil available over the counter?
Is remifentanil a controlled substance?
When was remifentanil first available?
Who makes remifentanil?
What is the brand name of remifentanil?
What is the generic name of Ultiva?
What drug class is remifentanil?
Is there a generic version of remifentanil?
What strengths does remifentanil come in?
Is there a remifentanil shortage?
Where can I read the remifentanil prescribing information (package insert)?
Is remifentanil gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Remifentanil
Skip the scrolling. Ask in your own words and get an answer from Remifentanil’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Remifentanil’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Remifentanil on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Remifentanil Forms and Strengths (How It Comes)
Remifentanil comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Remifentanil inactive ingredients by manufacturer.
Injection
How this form is used
- Remifentanil Hydrochloride for injection is used for pain control during general anesthesia, right after surgery in adults, and in adult monitored anesthesia care
- Ultiva is used for pain control during general anesthesia, right after surgery in adults, and in adult monitored anesthesia care
- Ultiva is for IV use only and must be diluted before use
- Remifentanil Hydrochloride for injection is for IV use only and must be diluted before use
- Ultiva continuous infusions are given only with an infusion device, and unused portions are discarded
- Ultiva IV tubing should be cleared after stopping to prevent accidental later doses
Remifentanil on the U.S. Market: Products, Makers and Brands
How Remifentanil appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
3 companies list 12 Remifentanil product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1996. The one brand name in the directory today is Ultiva; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (6) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Remifentanil Is Used (Medicaid Data)
How many Remifentanil prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Remifentanil prescribed? Of the 1,682 medications we measure, Remifentanil ranks #1,359 by Medicaid prescriptions — more than 19% of them.
Utilization by Remifentanil product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
remifentanil 2 MG Injection Most dispensed
3 of 11 listed NDCs had Medicaid claims. RxNorm 1729584
remifentanil 1 MG Injection
3 of 11 listed NDCs had Medicaid claims. RxNorm 1729578
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 6 of the 22 listed Remifentanil NDCs had Medicaid claims.
Compare Remifentanil Products
A representative set of FDA-listed product records for Remifentanil — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 1 mg/mL | Intravenous | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 1 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 2 mg/2 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 5 mg/5 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1 mg/mL | Intravenous | Mylan Institutional LLC × 6 listings | NDA | View NDC → |
Showing 12 of 12 products — FDA National Drug Code Directory. See every product, package size and price: browse all 12 Remifentanil NDCs →
Remifentanil Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Remifentanil — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Remifentanil in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Remifentanil FDA Approval History
How Remifentanil went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Remifentanil Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Remifentanil recalls since July 2021.
✅No Remifentanil recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Remifentanil in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 3
- Forms in current FDA listings
- 1 of 1
RxCUI 73032 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Remifentanil Supply and Shortage Status
Whether Remifentanil is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Remifentanil Brand Names
Remifentanil has one brand name on record: Ultiva. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Remifentanil: Manufacturers and Labelers
3 companies list Remifentanil products with the FDA. By number of product records, the largest are Mylan Institutional LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Remifentanil Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Mylan Institutional LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →